127 related articles for article (PubMed ID: 7760657)
21. Expression and secretion of endostatin in thyroid cancer.
Hoffmann S; Wunderlich A; Lingelbach S; Musholt PB; Musholt TJ; von Wasielewski R; Zielke A
Ann Surg Oncol; 2008 Dec; 15(12):3601-8. PubMed ID: 18818971
[TBL] [Abstract][Full Text] [Related]
22. Somatostatin analog octreotide inhibits the growth of differentiated thyroid cancer cells in vitro, but not in vivo.
Hoelting T; Duh QY; Clark OH; Herfarth C
J Clin Endocrinol Metab; 1996 Jul; 81(7):2638-41. PubMed ID: 8675590
[TBL] [Abstract][Full Text] [Related]
23. Invasion in follicular thyroid cancer cell lines is mediated by EphA2 and pAkt.
O'Malley Y; Lal G; Howe JR; Weigel RJ; Komorowski RA; Shilyansky J; Sugg SL
Surgery; 2012 Dec; 152(6):1218-24. PubMed ID: 23158188
[TBL] [Abstract][Full Text] [Related]
24. Adenylate cyclase, cyclic AMP and extracellular-signal-regulated kinase-2 in airway smooth muscle: modulation by protein kinase C and growth serum.
Moughal N; Stevens PA; Kong D; Pyne S; Pyne NJ
Biochem J; 1995 Mar; 306 ( Pt 3)(Pt 3):723-6. PubMed ID: 7702566
[TBL] [Abstract][Full Text] [Related]
25. Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism.
Shih A; Davis FB; Lin HY; Davis PJ
J Clin Endocrinol Metab; 2002 Mar; 87(3):1223-32. PubMed ID: 11889192
[TBL] [Abstract][Full Text] [Related]
26. Extracellular ATP stimulates three different receptor-signal transduction systems in FRTL-5 thyroid cells. Activation of phospholipase C, and inhibition and activation of adenylate cyclase.
Sato K; Okajima F; Kondo Y
Biochem J; 1992 Apr; 283 ( Pt 1)(Pt 1):281-7. PubMed ID: 1314567
[TBL] [Abstract][Full Text] [Related]
27. Stimulatory effect of vasoactive intestinal polypeptide on human normal and neoplastic thyroid tissue.
Siperstein AE; Miller RA; Clark OH
Surgery; 1988 Dec; 104(6):985-91. PubMed ID: 2848326
[TBL] [Abstract][Full Text] [Related]
28. Protein tyrosine phosphorylation induced by epidermal growth factor and insulin-like growth factor-I in a rat clonal dental pulp-cell line.
Kawase T; Orikasa M; Ogata S; Burns DM
Arch Oral Biol; 1995 Oct; 40(10):921-9. PubMed ID: 8526802
[TBL] [Abstract][Full Text] [Related]
29. The rise and fall of ceramide and 1,2-diacylglycerol (DAG): modulation by transforming growth factor-beta 1 (TGF beta 1) and by epidermal growth factor (EGF).
Goldkorn T; Ding T
Adv Exp Med Biol; 1997; 400A():461-72. PubMed ID: 9547591
[TBL] [Abstract][Full Text] [Related]
30. Alterations in TNF-alpha signal transduction in resistant human papillary thyroid carcinoma cells.
Pang XP; Ross NS; Hershman JM
Thyroid; 1996 Aug; 6(4):313-7. PubMed ID: 8875753
[TBL] [Abstract][Full Text] [Related]
31. Effects of sorafenib and an adenylyl cyclase activator on in vitro growth of well-differentiated thyroid cancer cells.
Sawa A; Chiba T; Ishii J; Yamamoto H; Hara H; Kamma H
Endocr J; 2017 Nov; 64(11):1115-1123. PubMed ID: 28855436
[TBL] [Abstract][Full Text] [Related]
32. Thyrotropin receptor-adenylate cyclase system in plasma membranes from normal and diseased human thyroid glands.
Carayon P; Guibout M; Lissitzky S
J Endocrinol Invest; 1978 Oct; 1(4):321-8. PubMed ID: 229150
[TBL] [Abstract][Full Text] [Related]
33. Different growth control of the two human thyroid cell lines of adenomatous goiter and papillary carcinoma.
Hishinuma A; Yamanaka T; Kasai K; So S; Tseng CC; Bamba N; Ohtake H; Shimoda S
Thyroid; 1995 Feb; 5(1):41-6. PubMed ID: 7787432
[TBL] [Abstract][Full Text] [Related]
34. Cell kinetics, DNA content and TSH receptor-adenylate cyclase system in differentiated thyroid cancer.
Chang TC; Kuo SH; Liaw KY; Chang CC; Chen FW
Clin Endocrinol (Oxf); 1988 Nov; 29(5):477-84. PubMed ID: 3253029
[TBL] [Abstract][Full Text] [Related]
35. The heat shock protein 90-binding geldanamycin inhibits cancer cell proliferation, down-regulates oncoproteins, and inhibits epidermal growth factor-induced invasion in thyroid cancer cell lines.
Park JW; Yeh MW; Wong MG; Lobo M; Hyun WC; Duh QY; Clark OH
J Clin Endocrinol Metab; 2003 Jul; 88(7):3346-53. PubMed ID: 12843186
[TBL] [Abstract][Full Text] [Related]
36. Distinct PKC isoforms mediate the activation of cPLA2 and adenylyl cyclase by phorbol ester in RAW264.7 macrophages.
Lin WW; Chen BC
Br J Pharmacol; 1998 Dec; 125(7):1601-9. PubMed ID: 9884090
[TBL] [Abstract][Full Text] [Related]
37. Regulation of cardiac adenylyl cyclase by epidermal growth factor (EGF). Role of EGF receptor protein tyrosine kinase activity.
Nair BG; Patel TB
Biochem Pharmacol; 1993 Oct; 46(7):1239-45. PubMed ID: 8216375
[TBL] [Abstract][Full Text] [Related]
38. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells.
Garcia R; Bowman TL; Niu G; Yu H; Minton S; Muro-Cacho CA; Cox CE; Falcone R; Fairclough R; Parsons S; Laudano A; Gazit A; Levitzki A; Kraker A; Jove R
Oncogene; 2001 May; 20(20):2499-513. PubMed ID: 11420660
[TBL] [Abstract][Full Text] [Related]
39. Dual bradykinin B2 receptor signalling in A431 human epidermoid carcinoma cells: activation of protein kinase C is counteracted by a GS-mediated stimulation of the cyclic AMP pathway.
Liebmann C; Graness A; Ludwig B; Adomeit A; Boehmer A; Boehmer FD; Nürnberg B; Wetzker R
Biochem J; 1996 Jan; 313 ( Pt 1)(Pt 1):109-18. PubMed ID: 8546671
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of epidermal growth factor receptor-associated tyrosine kinase blocks glioblastoma invasion of the brain.
Penar PL; Khoshyomn S; Bhushan A; Tritton TR
Neurosurgery; 1997 Jan; 40(1):141-51. PubMed ID: 8971836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]